DD-S052P
- Generic Name
- DD-S052P
New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
Phase 3
Completed
- Conditions
- Pneumonia, PneumococcalCommunity Acquired InfectionsGram-positive Bacterial Infections
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-04-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 230
- Registration Number
- NCT00035269
- Locations
- 🇨🇳
Research Center, Taoyuan, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath